Professional background
Dr Karim Keshwani graduated from University College London (UCL) in 2010 and completed his general (internal) medicine training and Membership to Royal College of Physicians (MRCP) in 2015. He completed his subspecialist clinical oncology training and Fellowship of the Royal College of Radiologists in 2022. He has a Masters in Medical Education completed in 2016 and Postgraduate Diploma in Oncology from the Institute of Cancer Research in 2022. He has been a Consultant Clinical Oncologist at UCLH since 2023 treating lung and blood cancers.
Lung cancers: Radical (curative) treatment of stage 1 - 3 (and radical treatment of oligometastatic and palliative treatments for stage 4) lung cancers to include Stereotactic Ablative Body Radiotherapy (SABR), radical, palliative and emergency radiotherapy techniques, as well as the use of systemic platinum-backbone concurrent chemotherapy and consolidation immunotherapy. Haematological cancers: Use of photon and proton beam therapy in the radical, palliative and emergency radiation treatment of haematological malignancies to include lymphoma, myeloma and leukaemia, including stem cell transplant conditioning total body irradiation, and CAR-T (Chimeric antigen receptor T-) cell bridging and consolidation radiation.
Specialties
Research interests
- Late phase clinical drug trial implementation in lung cancers.
- Optimising proton beam therapy and CAR-T radiation treatments in haematological cancers.
- Education, appraisal and service development